Despite the well-established renal protective effects of GLP-1 receptor agonists in cardiovascular and diabetes outcome trials, our analysis revealed an unexpected increase in acute kidney injury risk, suggesting that perioperative physiological stresses may alter the typical nephroprotective profile of these agents. Here, GLP1R is linked to diabetes mellitus.